Public recall detail

ACT-Candesartan 4mg tablets (2018-11-23)

medium
Recall Safety notice
Quick summary

Quick summary: ACT-Candesartan 4mg tablets (2018-11-23) .

Recommended action

Recommended action: compare your product with the official notice and follow the instructions published by the official source.

Recall details

Quick summary: ACT-Candesartan 4mg tablets (2018-11-23) .

Official details

Affected product details

Structured information extracted from the official recall notice. Confirm the identifiers and instructions in the original notice.

Brand

Affected products

DescriptionACT-Candesartan 4mg tablets DIN, NPN, DIN-HIM DIN 02376520 Dosage form Tablets Strength Candesartan Cilexetil 4mg Lot or serial number K49247, K49268, K49269, K50970, K50973, K51008 Companies Recalling Firm Teva Canada Ltd. 30 Novopharm Court Toronto M1B 2K9 Ontario CANADA Marketing Authorization Holder Teva Canada Ltd. 30 Novopharm Court Toronto M1B 2K9 Ontario CANADA
Additional official information
Background{}
Companies
Audiences

Contains information licensed under the Open Government Licence – Canada. SafetyPulse is independent of the Government of Canada.

Official source Monitor products Back to recalls

Starting...

Related recalls

Similar recalls and safety notices.

Loading related recalls...